What predicts non-retention in microbicide trials?

Contemporary Clinical Trials

Volumn 32, Issue 4, 2011, Pages 512-516

  Feldblum, Paul J ^a   Halpern, Vera ^a   Lie, Che Chin ^a   Obunge, Orikomaba ^b   Ogunsola, Folasade ^c   Ampofo, William ^d   Opoku, Kofi ^e  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF PORT HARCOURT   (Nigeria)

^c UNIVERSITY OF LAGOS   (Nigeria)

^d University of Ghana   (Ghana)

^e KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

HIV prevention; Loss to follow up; Microbicides; Proportional hazards modeling; Randomized controlled trials; Retention

Indexed keywords

CELLULOSE SULFATE; MICROBICIDE; PLACEBO; SAVVY; UNCLASSIFIED DRUG;

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; ARTICLE; BENIN; CANDIDIASIS; CONDOM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; GEL; GHANA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NIGERIA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SOUTH AFRICA; TREATMENT REFUSAL; UGANDA; VAGINITIS;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGE FACTORS; ANTI-INFECTIVE AGENTS, LOCAL; BETAINE; CELLULOSE; EARLY TERMINATION OF CLINICAL TRIALS; FATTY ACIDS, UNSATURATED; FEMALE; HIV INFECTIONS; HUMANS; PATIENT DROPOUTS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES; YOUNG ADULT;

EID: 79957478332     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.03.008     Document Type: Article

References (13)

1. Padian N.S., McCoy S.I., Balkus J.E., Wasserheit J.N. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010, 24:621-635.
2. Van Damme L., Ramjee G., Alary M., Vuylsteke B., Chandeying V., Rees H., et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002, 360:971-977.
3. Feldblum P.J., Adeiga A., Bakare R., Wevill S., Lendvay A., Obadaki F., et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS ONE 2008, 3:e1474.
4. Halpern V., Ogunsola F., Obunge O., Wang C.H., Onyejepu N., Oduyebo O., et al. Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria. PLoS ONE 2008, 3:e3784.
5. Peterson L., Nanda K., Opoku B.K., Ampofo W.K., Owusu-Amoako M., Boakye A.Y., et al. SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS ONE 2007, 2:e1312.
6. Van Damme L., Govinden R., Mirembe F.M., Guedou F., Solomon S., Becker M.L., et al. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med 2008, 359:463-472.
7. Graham S.M., Shah P.S., Aesch Z.C., Beyene J., Bayoumi A.M. A systematic review of the quality of trials evaluating biomedical HIV prevention interventions shows that many lack power. HIV Clin Trials 2009, 10:413-431.
8. Dhalla S., Nelson K.E., Singer J., Poole G. HIV vaccine preparedness studies in the non-Organization for Economic Cooperation and Development (non-OECD) countries. AIDS Care 2009, 21:335-348.
9. De Bruyn G., Hudgens M.G., Sullivan P.S., Duerr A.C. Participant retention in clinical trials of candidate HIV vaccines. J Acquir Immune Defic Syndr 2005, 39:499-501.
10. Gappoo S., Montgomery E.T., Gerdts C., Naidoo S., Chidanyika A., Nkala B., et al. Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. Contemp Clin Trials 2009, 30:411-418.
11. Karim Q.A., Karim S.S.A., Frolich J.A., et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174.
12. Feldblum P.J., Lie C.-C., Weaver M.A., Van Damme L., Halpern V., Adeiga A., et al. Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis 2010, 37:594-601.
13. Halpern V., Lie C-C, Feldblum P., Van Damme L. Microbicide Research Group. Predictors of pregnancy in microbicide trials. Contraception 2011, 83:436-440.